A Study of TG103 Injection in Type 2 Diabetes Subjects
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to evaluate the efficacy of different doses and
frequencies of administration of TG103 injection in the treatment of type 2 diabetes.